JPT Peptide Technologies provides innovative peptide based products and services for vaccine development, immuno monitoring and peptide biomarker discovery worldwide.

JPT's core technologies Spot™ and PepStar™ for peptide arrays; PepMix™ peptide pools; and PepTrack™ peptide libraries as well as its premium synthesis unit provide essential reagents that facilitate all phases of novel vaccines development.

We employ these proprietary technologies in a regulated environment at our state-of-the-art facilities. It is our ambition to enable:

• High performance T-cell assays (ELISPOT, ICS, CFS and others) for: T-cell epitope discovery; immune monitoring; vaccine efficacy testing; optimization and validation; adoptive immunotherapy
  (PepTrack™ peptide libraries, SPOT™ micro scale peptide sets)
• Proteome-wide antibody signature profiling and B-cell epitope discovery (PepStar™ peptide microarrays)
• Antibody epitope mapping (PepSpot™ membranes)
• In vitro profiling of anti-antibody / neutralizing antibody action (RepliTope™ peptide microarrays)
• Vaccine efficacy testing, immunomonitoring and immunotherapy research research
  (PepMix™ - antigen spanning and mixed epitope peptide pools)
• Development of peptide based vaccines and synthesis of peptide standards for validation of T-cell assays
  (state of the art custom peptide synthesis)

JPT helps to accelerate vaccine development in an unparalleled way. The regulated environment of our facilities, quality, turn-around time and price of our innovative products and services combined with the expertise and experience, and the responsiveness of our service make us a unique partner.